Q9ER38
Gene name |
Tor3a (Adir) |
Protein name |
Torsin-3A |
Names |
ATP-dependent interferon-responsive protein, Torsin family 3 member A |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:30935 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q9ER38
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q9ER38-F1 | Predicted | AlphaFoldDB |
24 variants for Q9ER38
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3390847442 | 13 | P>A | No | EVA | |
| rs13461644 | 42 | K>T | No | EVA | |
| rs249084461 | 94 | R>C | No | EVA | |
| rs3713711 | 94 | R>H | No | EVA | |
| rs254163032 | 100 | S>R | No | EVA | |
| rs3390836909 | 112 | T>S | No | EVA | |
| rs3390851740 | 113 | G>S | No | EVA | |
| rs31274029 | 119 | R>C | No | EVA | |
| rs13461646 | 164 | L>V | No | EVA | |
| rs3388509775 | 172 | L>M | No | EVA | |
| rs3388511718 | 204 | L>S | No | EVA | |
| rs3388504902 | 208 | M>I | No | EVA | |
| rs3388509761 | 239 | Y>N | No | EVA | |
| rs264692464 | 248 | R>H | No | EVA | |
| rs242418609 | 250 | V>A | No | EVA | |
| rs3388509587 | 277 | K>M | No | EVA | |
| rs3388509098 | 279 | G>R | No | EVA | |
| rs3388511634 | 286 | T>M | No | EVA | |
| rs31267896 | 287 | T>A | No | EVA | |
| rs3388509611 | 309 | S>N | No | EVA | |
| rs3388511695 | 314 | K>N | No | EVA | |
| rs236203689 | 315 | H>N | No | EVA | |
| rs13461645 | 329 | C>R | No | EVA | |
| rs3388510259 | 345 | P>L | No | EVA |
No associated diseases with Q9ER38
No regional properties for Q9ER38
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for Q9ER38 | |||
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| endoplasmic reticulum | The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). |
| endoplasmic reticulum lumen | The volume enclosed by the membranes of the endoplasmic reticulum. |
| nuclear envelope | The double lipid bilayer enclosing the nucleus and separating its contents from the rest of the cytoplasm; includes the intermembrane space, a gap of width 20-40 nm (also called the perinuclear space). |
2 GO annotations of molecular function
| Name | Definition |
|---|---|
| ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| ATP hydrolysis activity | Catalysis of the reaction: ATP + H2O = ADP + H+ phosphate. ATP hydrolysis is used in some reactions as an energy source, for example to catalyze a reaction or drive transport against a concentration gradient. |
No GO annotations of biological process
| Name | Definition |
|---|---|
| No GO annotations for biological process |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MFLGALWLLL | LLPLRPPGAQ | GQEADEPTPW | PSVKGLKEQL | RKAGALSKRY | WELFSCTLWP |
| 70 | 80 | 90 | 100 | 110 | 120 |
| DHCEDQETPV | PPLGWSLPLW | GRRSLDVLTA | WLCRFQDCCS | GGGDCRISNN | LTGLESDLRV |
| 130 | 140 | 150 | 160 | 170 | 180 |
| RLHGQHLASK | LVLRAVKGYL | EMPQVGKALA | LSFHGWSGTG | KNFLARILMD | NLYRDGMRSD |
| 190 | 200 | 210 | 220 | 230 | 240 |
| CVKMFISTFH | FPHPKYVDTY | KEELQRQMQE | TQWRCHQSTF | VFDEAEKLHP | GLLELLEPYL |
| 250 | 260 | 270 | 280 | 290 | 300 |
| EPRSPEARGV | EAPRAIFLFL | SNLGGSVINE | VVLSLLKAGW | SREEITTQHL | EVPLQAEIME |
| 310 | 320 | 330 | 340 | 350 | 360 |
| AADSSFGSSG | LLKKHLIDHF | IPFLPLEYCH | VRLCVRDAFL | GQDLPYTEET | LDEIAKMMTY |
| 370 | 380 | ||||
| VPEEERLFSS | QGCKSISQRI | NLFLP |